Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.

Autor: Routy B; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Lenehan JG; Department of Oncology, Western University, London, Ontario, Canada.; Lawson Health Research Institute, London, Ontario, Canada., Miller WH Jr; Lady Davis Institute of the Jewish General Hospital, Segal Cancer Centre, Montreal, Quebec, Canada.; Departments of Oncology and Medicine, McGill University, Montreal, Quebec, Canada., Jamal R; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Messaoudene M; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada., Daisley BA; Department of Microbiology & Immunology, Western University, London, Ontario, Canada.; Canadian Centre for Human Microbiome and Probiotics Research, London, Ontario, Canada., Hes C; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.; Peter Brojde Lung Cancer Center, Jewish General Hospital, Montreal, Quebec, Canada., Al KF; Lawson Health Research Institute, London, Ontario, Canada.; Department of Microbiology & Immunology, Western University, London, Ontario, Canada.; Canadian Centre for Human Microbiome and Probiotics Research, London, Ontario, Canada., Martinez-Gili L; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, St Mary's Hospital Campus, Imperial College London, London, UK.; Section of Bioinformatics, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK., Punčochář M; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Ernst S; Department of Oncology, Western University, London, Ontario, Canada., Logan D; Department of Oncology, Western University, London, Ontario, Canada., Belanger K; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.; Hematology-Oncology Division, Department of Medicine, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Esfahani K; Lady Davis Institute of the Jewish General Hospital, Segal Cancer Centre, Montreal, Quebec, Canada.; Departments of Oncology and Medicine, McGill University, Montreal, Quebec, Canada., Richard C; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada., Ninkov M; Department of Microbiology & Immunology, Western University, London, Ontario, Canada., Piccinno G; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Armanini F; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Pinto F; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Krishnamoorthy M; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada., Figueredo R; Department of Oncology, Western University, London, Ontario, Canada., Thebault P; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada., Takis P; Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, National Phenome Centre, Imperial College London, London, UK.; Section of Bioanalytical Chemistry, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Magrill J; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, Quebec, Canada., Ramsay L; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, Quebec, Canada., Derosa L; Gustave Roussy Cancer Campus, Villejuif, France.; Cancer Medicine Department, Gustave Roussy, Villejuif, France.; Institut National de la Santé Et et de la Recherche Médicale (INSERM) U1015, ClinicObiome, Equipe Labellisée-28 Ligue Nationale contre le Cancer, Villejuif, France.; Université Paris-Saclay, Ile-de-France, France., Marchesi JR; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, St Mary's Hospital Campus, Imperial College London, London, UK., Parvathy SN; Department of Medicine, Division of Infectious Diseases, Western University, London, Ontario, Canada.; Division of Infectious Diseases, St Joseph's Health Care, London, Ontario, Canada., Elkrief A; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada., Watson IR; Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, Quebec, Canada.; Department of Biochemistry, McGill University, Montréal, Quebec, Canada., Lapointe R; Research Center of the Centre Hospitalier de l'Université de Montréal, Montréal (CRCHUM), Montreal, Quebec, Canada.; Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, Quebec, Canada., Segata N; Department of Computational, Cellular and Integrative Biology, University of Trento, Trento, Italy., Haeryfar SMM; Lawson Health Research Institute, London, Ontario, Canada.; Department of Microbiology & Immunology, Western University, London, Ontario, Canada.; Department of Medicine, Division of Clinical Immunology and Allergy, Western University, London, Ontario, Canada.; Department of Surgery, Division of General Surgery, Western University, London, Ontario, Canada., Mullish BH; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, St Mary's Hospital Campus, Imperial College London, London, UK.; Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK., Silverman MS; Lawson Health Research Institute, London, Ontario, Canada.; Department of Microbiology & Immunology, Western University, London, Ontario, Canada.; Department of Medicine, Division of Infectious Diseases, Western University, London, Ontario, Canada.; Division of Infectious Diseases, St Joseph's Health Care, London, Ontario, Canada., Burton JP; Lawson Health Research Institute, London, Ontario, Canada.; Department of Microbiology & Immunology, Western University, London, Ontario, Canada.; Canadian Centre for Human Microbiome and Probiotics Research, London, Ontario, Canada., Maleki Vareki S; Department of Oncology, Western University, London, Ontario, Canada. saman.malekivareki@lhsc.on.ca.; Lawson Health Research Institute, London, Ontario, Canada. saman.malekivareki@lhsc.on.ca.; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada. saman.malekivareki@lhsc.on.ca.; Department of Medical Biophysics, Western University, London, Ontario, Canada. saman.malekivareki@lhsc.on.ca.; Ontario Institute of Cancer Research, Toronto, Ontario, Canada. saman.malekivareki@lhsc.on.ca.

Publikováno v: Nature medicine [Nat Med] 2024 Feb; Vol. 30 (2), pp. 604.

Single-cell spatial immune landscapes of primary and metastatic brain tumours.

Autor: Karimi E; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada., Yu MW; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Department of Physiology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Maritan SM; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada., Perus LJM; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Department of Physiology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Rezanejad M; Departments of Psychology and Computer Science, University of Toronto, Toronto, Ontario, Canada., Sorin M; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Dankner M; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada., Fallah P; Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada., Doré S; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Zuo D; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada., Fiset B; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada., Kloosterman DJ; Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands., Ramsay L; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada., Wei Y; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada., Lam S; Department of Diagnostic Radiology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Alsajjan R; Department of Medicine, Division of Neurology, King Saud University College of Medicine, Riyadh, Saudi Arabia.; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Watson IR; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Department of Biochemistry, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Roldan Urgoiti G; Department of Oncology, University of Calgary, Calgary, Alberta, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Park M; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada.; Department of Biochemistry, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Senger DL; Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada.; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Chan JA; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada., Akkari L; Division of Tumor Biology and Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, Netherlands., Petrecca K; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.; Montreal Neurological Institute-Hospital, McGill University Health Centre, Montreal, Quebec, Canada., Guiot MC; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.; Montreal Neurological Institute-Hospital, McGill University Health Centre, Montreal, Quebec, Canada.; Department of Pathology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada., Siegel PM; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada. peter.siegel@mcgill.ca.; Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada. peter.siegel@mcgill.ca.; Department of Biochemistry, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. peter.siegel@mcgill.ca.; Department of Anatomy and Cell Biology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. peter.siegel@mcgill.ca., Quail DF; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada. daniela.quail@mcgill.ca.; Department of Physiology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. daniela.quail@mcgill.ca.; Department of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada. daniela.quail@mcgill.ca., Walsh LA; Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada. logan.walsh@mcgill.ca.; Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, Quebec, Canada. logan.walsh@mcgill.ca.

Publikováno v: Nature [Nature] 2023 Feb; Vol. 614 (7948), pp. 555-563. Date of Electronic Publication: 2023 Feb 01.

Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy.

Autor: Rajkumar S; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada., Berry D; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada., Heney KA; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada., Strong C; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada., Ramsay L; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada., Lajoie M; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada., Alkallas R; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Human Genetics, McGill University, Montréal, QC H3A 0C7, Canada., Nguyen TT; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada., Thomson C; University of Massachusetts Chan Medical School, Worcester, MA 01655, USA., Ahanfeshar-Adams M; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada., Dankner M; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada., Petrella T; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada., Rose AAN; Department of Oncology, McGill University, Montréal, QC H4A 3T2, Canada; Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, Montréal, QC H3T 1E2, Canada., Siegel PM; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada; Department of Medicine, McGill University, Montréal, QC H4A 3J1, Canada., Watson IR; Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada; Research Institute of the McGill University Health Centre, Montréal, QC H3H 2R9, Canada. Electronic address: ian.watson2@mcgill.ca.

Publikováno v: Cell reports [Cell Rep] 2022 Apr 05; Vol. 39 (1), pp. 110634.

The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.

Autor: Karachaliou GS; Department of Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA., Alkallas R; Department of Biochemistry, McGill University, Montreal, QC, Canada., Carroll SB; Department of Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA., Caressi C; California Pacific Medical Center Research Institute, San Francisco, CA, USA., Zakria D; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Patel NM; Department of Pathology & Laboratory Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Trembath DG; Department of Pathology & Laboratory Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA., Ezzell JA; Department of Cell Biology & Physiology, Histology Research Core Facility, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Pegna GJ; Department of Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA., Googe PB; Department of Dermatology, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA., Galeotti JP; Department of Pathology & Laboratory Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA., Ayvali F; Department of Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA., Collichio FA; Department of Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Lee CB; Department of Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Ollila DW; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Surgery, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA., Gulley ML; Department of Pathology & Laboratory Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Johnson DB; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Kim KB; California Pacific Medical Center Research Institute, San Francisco, CA, USA., Watson IR; Department of Biochemistry, McGill University, Montreal, QC, Canada., Moschos SJ; Department of Medicine, The University of North Carolina at Chapel Chapel Hill, Chapel Hill, NC, USA. moschos@med.unc.edu.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. moschos@med.unc.edu.

Publikováno v: BMC cancer [BMC Cancer] 2022 Jan 05; Vol. 22 (1), pp. 38. Date of Electronic Publication: 2022 Jan 05.